Both the survival analysis and the in vivo study of TRIM37 were required to further investigate the bio-function of TRIM37 in the malignization of T-ALL and the association between TRIM37 and the clinical prognosis of T-ALL patients. This evidence concerns the gene TRIM37 and acute lymphoblastic leukemia.